Atea Pharmaceuticals Inc Financial Flexibility Index
Atea Pharmaceuticals Inc financial flexibility index. Atea Pharmaceuticals Inc (AVIR) has a Financial Flexibility Index of -1.32x as of June 2026. Free cash flow of $-37.08 Million (operating CF $-37.08 Million minus capex $0.00) represents -1% of total liabilities ($28.12 Million). See Atea Pharmaceuticals Inc free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Atea Pharmaceuticals Inc (2018–2025)
Financial flexibility index of Atea Pharmaceuticals Inc from 2018 to 2025. Historical Financial Flexibility Index trend for Atea Pharmaceuticals Inc across 8 annual periods. Check Atea Pharmaceuticals Inc (AVIR) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
Atea Pharmaceuticals Inc Financial Flexibility Index by Year (2018–2025)
Atea Pharmaceuticals Inc financial flexibility index by year from 2018 to 2025. Year-by-year free cash flow to debt coverage for Atea Pharmaceuticals Inc. For the full cash flow conversion analysis, see cash flow conversion of Atea Pharmaceuticals Inc.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -3.32x | $-132.03 Million | $-132.03 Million | $39.78 Million | ▲ +36.8% |
| 2024 | -5.25x | $-135.50 Million | $-135.50 Million | $25.80 Million | ▼ -144.6% |
| 2023 | -2.15x | $-85.39 Million | $-85.39 Million | $39.78 Million | ▲ +52.9% |
| 2022 | -4.55x | $-119.04 Million | $-120.98 Million | $26.14 Million | ▼ -228.8% |
| 2021 | -1.39x | $-87.00 Million | $-87.00 Million | $62.81 Million | ▼ -247.4% |
| 2020 | 0.94x | $296.76 Million | $296.73 Million | $315.83 Million | ▲ +625.4% |
| 2019 | -0.18x | $-12.81 Million | $-12.81 Million | $71.64 Million | ▼ -60.9% |
| 2018 | -0.11x | $-7.90 Million | $-7.91 Million | $71.02 Million | — |